Simon Nigen

Increased expression of <scp>IL</scp>‐17A and limited involvement of <scp>IL</scp>‐23 in patients with palmo‐plantar (<scp>PP</scp>) pustular psoriasis or <scp>PP</scp> pustulosis; results from a randomised controlled trial

Robert Bissonnette, Simon Nigen, Richard G. Langley et al. · Journal of the European Academy of Dermatology and Venereology · 2013 · 110 citations

Drug eruptions: approaching the diagnosis of drug-induced skin diseases.

Simon Nigen, Sandra R Knowles, Neil H. Shear · PubMed · 2003 · 108 citations

Toxic Epidermal Necrolysis, Pharmacotherapy, Dermatology +16

Efficacy and safety of topical WBI‐1001 in patients with mild to moderate psoriasis: results from a randomized double‐blind placebo‐controlled, phase II trial

Robert Bissonnette, Chantal Bolduc, Catherine Maari et al. · Journal of the European Academy of Dermatology and Venereology · 2011 · 71 citations

Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.

Carrie Brodmerkel, Eric Wadman, Richard G. Langley et al. · PubMed · 2013 · 69 citations

Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study

Robert Bissonnette, Yves Poulin, Lyn Guenther et al. · Journal of the European Academy of Dermatology and Venereology · 2011 · 67 citations · Full text